Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Lipocine Inc.:
We consent to the use of our report dated July 24, 2013, with respect to the balance sheets of Lipocine Inc. as of December 31, 2012 and 2011, and the related statements of operations, changes in stockholders’ equity , and cash flows for each of the years in the two-year period ended December 31, 2012 included herein.
/s/ KPMG LLP
Salt Lake City, Utah
July 24, 2013
